Form 4 for IGC IGC Pharma, Inc.
Accepted 2026-04-06 16:02:29 ET · period of report 2026-04-01 · accession 0001185185-26-001285 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-04-06 16:02 | 2026-04-01 | IGC | Mukunda Ram | CEO, Dir | M - OptEx | $0.128 | +656.4K | 4.65M | +16% | +$84.0K |
| DMI | 2026-04-06 16:02 | 2026-04-01 | IGC | Mukunda Ram | CEO, Dir | M - OptEx | $0.00 | +50.0K | 910.8K | +6% | $0 |
| DM | 2026-04-06 16:02 | 2026-04-01 | IGC | Mukunda Ram | CEO, Dir | M - OptEx | $0.00 | -656.4K | 676.9K | -49% | $0 |
| DMI | 2026-04-06 16:02 | 2026-04-01 | IGC | Mukunda Ram | CEO, Dir | M - OptEx | $0.00 | -50.0K | 33.3K | -60% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-01 | M | A | 333,333 | $0.00 | 4,326,011 | D | — | — | (F1) On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2024. |
| 2 | Common | Common Stock | 2026-04-01 | M | A | 323,077 | $0.26 | 4,649,088 | D | — | — | (F2) On March 13, 2024, the Reporting Person was granted options exercisable at $0.26, vesting over three years starting in March 2025. |
| 3 | Common | Common Stock | 2026-04-01 | M | A | 16,667 | $0.00 | 877,419 | I BY SPOUSE | — | — | (F3) On June 26, 2025, the Reporting Person's spouse was granted RSUs. |
| 4 | Common | Common Stock | 2026-04-01 | M | A | 33,332 | $0.00 | 910,751 | I BY SPOUSE | — | — | (F4) On February 3, 2026, the Reporting Person's spouse was granted RSUs. |
| 5 | Derivative | Restricted Stock Units | 2026-04-01 | M | D | 333,333 | $0.00 | 0 | D | — · — to — | 333,333 Common Stock | (F5) Each restricted stock unit represents a right to receive one share of IGC common stock. (F1) On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2024. (F1) On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2024. (F1) On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2024. |
| 6 | Derivative | Options | 2026-04-01 | M | D | 323,077 | $0.00 | 676,925 | D | $0.26 · — to 2034-03-12 | 323,077 Common Stock | (F2) On March 13, 2024, the Reporting Person was granted options exercisable at $0.26, vesting over three years starting in March 2025. (F2) On March 13, 2024, the Reporting Person was granted options exercisable at $0.26, vesting over three years starting in March 2025. |
| 7 | Derivative | Restricted Stock Units | 2026-04-01 | M | D | 16,667 | $0.00 | 0 | I BY SPOUSE | — · — to — | 16,667 Common Stock | (F5) Each restricted stock unit represents a right to receive one share of IGC common stock. (F3) On June 26, 2025, the Reporting Person's spouse was granted RSUs. (F3) On June 26, 2025, the Reporting Person's spouse was granted RSUs. (F3) On June 26, 2025, the Reporting Person's spouse was granted RSUs. |
| 8 | Derivative | Restricted Stock Units | 2026-04-01 | M | D | 33,332 | $0.00 | 33,334 | I BY SPOUSE | — · — to — | 33,332 Common Stock | (F5) Each restricted stock unit represents a right to receive one share of IGC common stock. (F4) On February 3, 2026, the Reporting Person's spouse was granted RSUs. (F4) On February 3, 2026, the Reporting Person's spouse was granted RSUs. (F4) On February 3, 2026, the Reporting Person's spouse was granted RSUs. |